SCHEMBL2644375

SCHEMBL2644375

CC(=O)c1cc(-c2cnnc(-c3ccc(F)cc3F)n2)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
TTR P02766 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
DHFR P00374 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
ALB P02768 1/20 0.40
HMGB1 P09429 1/20 0.40
HPGD P15428 1/20 0.40
CXCL12 P48061 1/20 0.40
KMT2A Q03164 1/20 0.40
HIF1A Q16665 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
ACMSD Q8TDX5 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2644672 0.79 GABRG2 (0.43) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645141 0.79 ALDH1A1 (0.42) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645113 0.77 GABRG2 (0.46) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2644388 0.77 MPL (0.45) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645812 0.76 GABRG2 (0.47) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2644597 0.76 GABRG2 (0.46) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2644646 0.75 GABRG2 (0.43) ALDH1A1KDM4EHPGDGAAGABRG2
SCHEMBL2645140 0.74 ALDH1A1 (0.41) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL2645638 0.73 GABRG2 (0.47) GABRG2GABRB3GABRA5GABRA3
SCHEMBL2644133 0.73 GABRG2 (0.48) ALDH1A1CYP1A2GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6969716-B2 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression MERCK SHARP & DOHME LTD. 2005-11-29 US disclosed
US-20040192692-A1 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression MERCK SHARP & DOHME, LTD. (GB) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192692-A1 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression GABRA1, GABRA5, GABRA2 ALDH1A1 260/4885TTR 2679/4885KDM4E 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.